DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Vijaya Diagnostic Centre Limited — Cessation

NSE 1 hr ago·21 Aug 2026, 1:43 pm

Vijaya Diagnostic CEN

Vijaya Diagnostic Centre Limited has announced the resignation of Dr. Manjula Anagani from her position as a Non-Executive Independent Director. Her term as a director was scheduled to conclude on August 21, 2026.

The company has stated that Dr. Anagani's resignation is not due to any disagreement with the board or management. Her departure will not impact the company's operations or financial performance. Investors should note that this is a routine administrative change involving an independent director.

Investors should monitor the company's future announcements to identify her replacement. The appointment of a new independent director is a standard governance process and is not expected to influence the company's strategic direction or stock performance.